ARTICLE
28 April 2011

Parliament Tightened Rules For The Advertising Of Medical Goods

CC
CMS Cameron McKenna Nabarro Olswang

Contributor

CMS is a Future Facing firm with 79 offices in over 40 countries and more than 5,000 lawyers globally. Combining local market insight with a global perspective, CMS provides business-focused advice to help clients navigate change confidently. The firm's expertise and innovative approach anticipate challenges and develop solutions. CMS is committed to diversity, inclusivity, and corporate social responsibility, fostering a supportive culture. The firm addresses key client concerns like efficiency and regulatory challenges through services like Law-Now, offering real-time eAlerts, mobile access, an extensive legal archive, specialist zones, and global events.

On 19 April 2011, the Ukrainian Parliament adopted a draft law introducing changes to article 21 of the law of Ukraine on Advertising.
Ukraine Media, Telecoms, IT, Entertainment

On 19 April 2011, the Ukrainian Parliament adopted a draft law introducing changes to article 21 of the law of Ukraine on Advertising.

This draft law amends the existing Ukrainian law on advertising, by introducing an additional requirement as to the content of advertisements for medicines, medical equipment, and methods of treatment and diagnosis.

According to the newly adopted draft law, any public advertisement of medicines must also contain the specific warning "self-treatment can be harmful for health". Moreover, this warning should cover at least fifteen percent of the square or duration of the advertisement.

The existing wording of the law on advertising provides that the advertisement of medicines should contain impartial information about the medicine and should clearly state (i) that the information which is being communicated is an advertisement, (ii) that the advertised product is a medicine, (iii) that it is recommended that a doctor be consulted prior to the use of the medicine and (iv) that the leaflet enclosed with the medicine should be studied before use of the medicine.

The new draft law has yet to be signed in to law by the Ukrainian President and is scheduled to become effective three months after the date of its official publication, but if it does become effective in its current form the new draft law will expand the list of requirements in relation to the advertisement of medicines.

This article was written for Law-Now, CMS Cameron McKenna's free online information service. To register for Law-Now, please go to www.law-now.com/law-now/mondaq

Law-Now information is for general purposes and guidance only. The information and opinions expressed in all Law-Now articles are not necessarily comprehensive and do not purport to give professional or legal advice. All Law-Now information relates to circumstances prevailing at the date of its original publication and may not have been updated to reflect subsequent developments.

The original publication date for this article was 26/04/2011.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More